Hepatitis C virus core protein represses p21(WAF1/Cip1/Sid1) promoter activity

Gene

Volumn 208, Issue 2, 1998, Pages 331-336

  Ray, Ratna B ^a   Steele, Robert ^a   Meyer, Keith ^a   Ray, Ranjit ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gel mobility shift analysis; Luciferase assay; p21; Transcriptional repression

Indexed keywords

CORE PROTEIN; CYCLIN DEPENDENT KINASE; ENZYME INHIBITOR; PROTEIN P21; PROTEIN P53; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; EUKARYOTIC CELL; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE REPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN FAMILY; TRANSCRIPTION REGULATION; UTERINE CERVIX CARCINOMA; VIRUS PATHOGENESIS;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GLUTATHIONE TRANSFERASE; HELA CELLS; HEPACIVIRUS; HEPATITIS C ANTIGENS; HUMANS; LIVER NEOPLASMS; LUCIFERASES; MICE; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED; VIRAL CORE PROTEINS;

EID: 0032570876     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(98)00030-4     Document Type: Article

References (46)

1. Aguilar F., Harris C.C., Sun T., Hollstein M., Cerutti P. Geographic variation of p53 mutational profile in malignant human liver. Science. 264:1994;1317-1319.
2. WAF1/Cip1/Sdi1 gene expression in hepatic regeneration. Hepatology. 25:1997;557-563.
3. Andrews N.C., Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:1991;2499.
4. Barba G., Harper F., Harada T., Kohara M., Goulinet S., Matsuura Y., Eder G., Schaff Z., Chapman M.J., Miyamura T., Brechot C. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc. Natl. Acad. Sci. USA. 94:1997;1200-1205.
5. Bukh J., Purcell R.H., Miller R.H. Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc. Natl. Acad. Sci. USA. 91:1994;8239-8243.
6. Choo Q.-L., Richman K.H., Han J.H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby A., Barr P.J., Weiner A.J., Bradley D.W., Kuo G., Houghton M. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA. 88:1991;2451-2455.
7. Datto M.B., Yu Y., Wang X-F. Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270:1995;28623-28628.
8. Datto M.B., Hu P.P.C., Kowalik T.F., Yingling J., Wang X.F. The viral oncoprotein E1A blocks transforming growth factor beta-mediated induction of p21/WAF1/Cip1 and p15/INK4B. Mol. Cell Biol. 17:1997;2030-2037.
9. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
10. El-Deiry W.S., Harper J.W., O'Conor P.M., Velculescu V.E., Canman C.E., Jackman J., Pietenpol J.A., Burrell M., Hill D.E., Yang Y. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1994;1169-1174.
11. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 55:1995;2910-2919.
12. 2. Mol. Cell Biol. 16:1996;762-770.
13. Gorospe M., Cirielli C., Wang X., Seth P., Capogrossi M.C., Holbrook N.J. p21-Waf1/Cip1 protects against p53-mediated apoptosis of human melanoma cells. Oncogene. 14:1997;929-935.
14. Grakoui A., Wychowski C., Lin C., Feinstone S.M., Rice C.M. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67:1993;1385-1395.
15. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
16. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. USA. 88:1991;5547-5551.
17. Hitomi Y., McDonnel W.M., Baker J.R. Jr., Askari F.K. High efficiency prokaryotic expression and purification of a portion of the hepatitis C virus core protein and analysis of the immune response to recombinant protein in BALB/c mice. Viral Immunol. 8:1995;109-119.
18. Hsu I.C., Metcalf R.A., Sun T., Welsh J.A., Wang N.J., Harris C.C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 350:1991;427-428.
19. WAF1/CIP1 expression and p53 mutation in hepatocellular carcinomas. Hepatology. 25:1997;575-579.
20. Kane J.M., Shears L.L., Hierholzer C., Ambs S., Billiar T.R., Posner M.C. Chronic hepatitis C virus infection in humans - induction of hepatic nitric oxide synthase and proposed mechanisms for carcinogenesis. J. Surg. Res. 69:1997;321-324.
21. Kobayashi T., Consoli U., Andreeff M., Shiku H., Zhang W. Activation of p21WAF1/Cip1 expression by a temperature-sensitive mutant of human p53 does not lead to apoptosis. Oncogene. 11:1995;2311-2316.
22. Lagging L.M., Meyer K., Hoft D., Houghton M., Belshe R.B., Ray R. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J. Virol. 69:1995;5859-5863.
23. WAF1/CIP1 expression through mitogen- activated protein kinase signaling pathway. Cancer Res. 56:1996;31-35.
24. Lo S., Masiarz F., Hwang S.B., Lai M.M.C., Ou J. Different subcellular localization of hepatitis C virus core gene products. Virology. 213:1995;455-461.
25. Matsumoto M., Hsieh T-Y, Zhu N., VanArsdale T., Hwang S.B., Jeng K-S, Gorbalenya A.E., Lo S-Y, Ou J-S, Ware C.F., Lai M.M.C. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-β receptor. J. Virol. 71:1997;1301-1309.
26. Michiell P., Chedid M., Lin D., Pierce J.H., Mercer W.E., Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54:1994;3391-3395.
27. Mihm S., Fayyazi A., Ramadori G. Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection - relation to hepatic viral load and liver injury. Hepatology. 26:1997;451-458.
28. Morgan D.O. Principles of CDK regulation. Nature. 374:1995;131-134.
29. Moriya K., Yotsuyanagi H., Shintani Y., Fujie H., Ishibashi K., Matsuura Y., Miyamura T., Koike K. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J. Gen. Virol. 78:1997;1527-1531.
30. Ray R.B., Miller D.M. Cloning and characterization of a human c-myc promoter binding protein. Mol. Cel. Biol. 11:1991;2154-2161.
31. Ray R.B., Lagging L.M., Meyer K., Steele R., Ray R. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res. 37:1995;209-220.
32. Ray R.B., Meyer K., Ray R. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology. 226:1996;176-182.
33. Ray R.B., Lagging L.M., Meyer K., Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J. Virol. 70:1996;4438-4443.
34. Ray R.B., Steele R., Meyer K., Ranjit R. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J. Biol. Chem. 272:1997;10983-10986.
35. Saito I., Miyamura T., Ohbayashi A., Harada H., Katayama T., Kikuchi S., Watanabe Y., Koi S., Onji M., Choo Q-L, Houghton M., Kuo G. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 87:1990;6547-6549.
36. Santolini E., Migliaccio G., La Monica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J. Virol. 68:1994;3631-3641.
37. Sheikh M.S., Rochefort H., Garcia M. Overexpression of p21WAF1/CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene. 11:1995;1899-1905.
38. Shih C.M., Lo S.J., Miyamura T., Chen S.Y., Lee Y.W. Suppression of Hepatitis B virus expression and replication by Hepatitis C virus core protein in HuH-7 cells. J. Virol. 67:1993;5823-5832.
39. Songsivilai S., Dharakul T., Kunkitti R., Thepthai C. Molecular cloning and expression of hepatitis C virus core protein and production of monoclonal antibodies to the recombinant protein. Asian Pacific J. Allergy Immunol. 14:1996;31-41.
40. Srinivas R.V., Ray R.B., Meyer K., Ray R. Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication. Virus Res. 45:1996;87-92.
41. Skapek S.X., Rhee J., Spicer D.B., Lassar A.B. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science. 267:1995;1022-1024.
42. Tsao Y.P., Li L.Y., Tsai T.C., Chen S.L. Human papilloma virus type 11 and 16 E5 represses p21 (Waf1/SdiI/CipI) gene expression in fibroblasts and keratinocytes. J. Virol. 70:1996;7535-7539.
43. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
44. Yang Z-Y., Perkins N.D., Ohno T., Nabel G.J. The p21 cyclin dependent kinase inhibitor suppresses tumorigenicity in vivo. Nature Med. 1:1995;1052-1056.
45. Zeng Y-X, El-Deiry W.S. Regulation of p21WAF1/CIP1 expression by p53- independent pathways. Oncogene. 12:1996;1557-1564.
46. Zeng Y.X., Somasundaram K., El-Deiry W.S. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nature Genet. 15:1997;78-82.